Table 1 Comparison of baseline clinical characteristics based on HMGB2 expression level
HMGB2 | χ2 value | P value | ||||
|---|---|---|---|---|---|---|
Variable | n | Low (%) | High (%) | |||
Age | 0.140 | 0.904 | ||||
≤55 | 86 | 34(45.9) | 52(46.8) | |||
> 55 | 99 | 40(54.1) | 59(53.2) | |||
Tumor Diameter | 9.05 | 0.003 | ||||
< 2 cm | 73 | 39(52.7) | 34(30.6) | |||
≥2 cm | 112 | 35(47.3) | 77(69.4) | |||
Grade | 2.016 | 0.365 | ||||
I | 96 | 43(58.1) | 53 (47.7) | |||
II | 70 | 25(33.8) | 45(40.5) | |||
III | 19 | 6(8.1) | 13(11.7) | |||
Stage | 6.801 | 0.033 | ||||
I | 26 | 12(16.2) | 14(12.6) | |||
II | 75 | 37(50.0) | 38(34.2) | |||
III | 84 | 25(9.8) | 59(53.2) | |||
Subtypes | 4.733 | 0.129 | ||||
Luminal A | 88 | 40(54.1) | 48(43.2) | |||
Luminal B | 42 | 13(17.6) | 29(26.1) | |||
Basal-like | 33 | 10(13.5) | 23(20.7) | |||
Her-2+ | 22 | 11(14.9) | 11(9.9) | |||
ER Status | 1.20 | 0.273 | ||||
Negative | 48 | 16(21.6) | 32(28.8) | |||
Positive | 137 | 58(78.4) | 79(71.2) | |||
PR Status | 2.183 | 0.140 | ||||
Negative | 72 | 24(32.7) | 48(43.2) | |||
Positive | 113 | 50(67.6) | 63(56.8) | |||
HER-2/neu Status | 0.498 | 0.480 | ||||
Negative | 152 | 59(79.7) | 93(83.8) | |||
Positive | 33 | 15(20.3) | 18(16.2) | |||